This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Burn of respiratory tract, unspecified (Respiratory tract burn, site unspecified — guidance on applying the NOS code and clinical approach) (Burn of Respiratory Tract, Unspecified — T27.3 NOS)

ICD-10: T27.3 (burn of respiratory tract, unspecified) | Special Copayment Reduction: V250 (special copayment reduction for severe burns, category 4: burns of the respiratory and alimentary tracts; 5% copayment for 1 year from the registration date)

S1. Definition and application principles of the T27.3 code

ICD-10 T27.3 is "Burn of respiratory tract, part unspecified", a NOS (Not Otherwise Specified) residual code applied when an inhalation burn has been clinically confirmed but the anatomical site involved cannot be specified. It is used temporarily when none of the three codes T27.0 (larynx·trachea), T27.1 (larynx·trachea·lung) and T27.2 (other parts of the respiratory tract) can readily be applied, or when the exact anatomical extent cannot be confirmed at the initial assessment stage.

According to clinical coding guidance, T27.3 is used in the following situations: ① temporary coding during initial emergency department assessment while awaiting results of confirmatory tests such as bronchoscopy and chest CT; ② when an inhalation burn is diagnosed from clinical symptoms and inhalation history alone without bronchoscopy; ③ in fire-scene fatalities, before autopsy or when inhalation injury is confirmed at autopsy but description of the specific anatomical site is insufficient. In principle, the code should be updated to T27.0~T27.2 or T27.1 (combined involvement) after confirmatory testing whenever possible.

Principle of coding updates: T27.3 is a temporary code and should be converted to the appropriate code among T27.0~T27.2 within 3 days of admission based on bronchoscopy or imaging results. T27.3 is used as the final code only when the site remains unspecified until discharge.

Because special copayment reduction V250 applies equally to all of T27.0~T27.3, eligibility and benefits for special copayment reduction registration are maintained even if the code is changed from T27.3 to a more specific code. A 5% copayment applies for 1 year from the registration date.

S2. Epidemiological overview of inhalation burns

Inhalation burns are a major cause of fire-related death, increasing mortality 4~5-fold compared with skin burns alone. According to statistics of the US ABA (American Burn Association), inhalation burns accompany about 20~35% of hospitalized burn patients, and in about half of these the inhalation burn acts as the main cause of death. In Korean National Fire Agency statistics, about 60~70% of fire deaths result from inhalation of smoke and toxic gases.

The main risk factor for inhalation burns is enclosed-space fire. In enclosed spaces, toxic gas concentrations rise rapidly and the partial pressure of oxygen falls, causing combined injury. Combustion of synthetic materials common in house fires (polyurethane, PVC, nylon) produces various toxic gases such as hydrogen cyanide (HCN), phosgene, hydrogen chloride and sulfur dioxide. Inhalation burns are also frequent in occupationally exposed groups (firefighters, chemical plant workers).

Correlation with skin burns: inhalation burns and skin burns frequently coexist but are not necessarily proportional. Inhalation burns accompany about 30% of patients with extensive skin burns (TBSA >40%), but pure inhalation burns without skin burns also exist. Children are more vulnerable to inhalation burns than adults because their narrow airway diameter makes airway obstruction from edema more likely, and their high minute ventilation results in relatively greater inhalation of toxic gases.

S3. Integrated understanding of inhalation burn pathophysiology

The pathophysiology of inhalation burns involves three main injury mechanisms acting in combination.

1) Thermal injury: Hot gases exchange heat mainly in the upper airway and are poorly transmitted below the glottis. However, steam can cause thermal injury down to the lower airways because of the high heat capacity of water. Upper airway thermal injury leads to mucosal edema, vasodilation and airway obstruction.

2) Chemical injury: Products of incomplete combustion such as aldehydes (acrolein, formaldehyde), acids (HCl, HNO₃) and organic toxins react with the airway mucosa, causing mucosal necrosis, loss of ciliary function, airway hypersecretion and bronchospasm. The anatomical distribution of chemical injury depends on the water solubility of the substance.

3) Systemic toxins: CO (carbon monoxide) blocks the oxygen-carrying capacity of hemoglobin and inhibits intracellular cytochrome oxidase. HCN (hydrogen cyanide) blocks the mitochondrial electron transport chain, causing hypoxia at the cellular level. These two toxins can cause fatal systemic toxicity even without skin burns.

Because of the combination of the three mechanisms, the clinical course of inhalation burns unfolds in three stages: ① upper airway obstruction (early threat), ② lower airway chemical pneumonitis (delayed threat), and ③ systemic toxin effects (immediate·sustained threat).

S4. Initial on-scene assessment and emergency care

In on-scene care of patients with inhalation burns, rapid rescue from the hazardous environment and securing the airway are the top priorities. For the rescuer's own safety, enclosed fire spaces are not entered without a self-contained breathing apparatus (SCBA).

Sequence of on-scene care:

  1. Move the patient to a safe place (stop further exposure)
  2. Secure the airway: sitting position for conscious patients; chin lift-head tilt or jaw thrust for unconscious patients
  3. High-flow oxygen: 100% O₂, non-rebreather mask (NRB mask), 15 L/min → shortens CO half-life (room air: 4~5 hours → 100% O₂: 60~90 minutes)
  4. Assess level of consciousness (AVPU or GCS)
  5. Assess burn area and start fluids (if IV access is possible on scene)
  6. Cool skin burn areas with cool water (15~25°C) for 20 minutes (beware of hypothermia)

Monitoring during transport: SpO₂ (overestimated in CO poisoning — co-oximetry needed for accurate measurement of blood oxygen saturation), EKG monitoring (arrhythmia surveillance), tracking changes in consciousness. Paramedics notify the emergency department in advance of on-scene information (whether the space was enclosed, materials burned, exposure time, any loss of consciousness).

Pitfall of SpO₂: In patients with carbon monoxide poisoning, standard pulse oximetry can mistake COHb for oxyhemoglobin and display a normal SpO₂. Co-oximetry (ABGA) or a CO-oximeter should be used in all patients suspected of CO poisoning.

S5. Systematic emergency department assessment protocol

Emergency department assessment of patients with suspected inhalation burns is carried out rapidly in ABCDE order, with additional assessment of indicators specific to inhalation burns.

Clinical indicators of inhalation burns (6):

If two or more of these are present, the patient is classified as high risk for inhalation burns, bronchoscopy is planned immediately and ICU monitoring is started. If stridor is present or rapid progression of airway edema is expected, intubation is performed without delay.

Essential tests: ABGA + co-oximetry (COHb, MetHb), complete blood count, liver function, renal function, electrolytes, serum lactate (>8 mmol/L in HCN toxicity), cardiac enzymes (to rule out myocardial injury), 12-lead electrocardiography, chest X-ray, blood cyanide (if available). In skin burn patients with concomitant inhalation burns, fluid requirements often increase by 20~30% above the Parkland formula (4 mL/kg/TBSA%).

S6. Severity classification tools for inhalation burns

Standardized tools for objectively classifying the severity of inhalation burns are still under development, but the following classification systems are used clinically.

Classification toolBasisGradeMain use
Mlcak-Cancio bronchoscopic classificationBronchoscopic findingsGrades 0~4Diagnosis and severity of inhalation burns
Abbreviated Burn Severity Index (ABSI)Age, sex, burn area, inhalation burnSum of pointsPrediction of overall survival
Baux ScoreAge + TBSA%Sum of pointsMortality prediction; +17 adjustment for inhalation burn
FLAMES ScoreFiO₂, lactate, age, mechanical ventilation, inhalation burn, burn area0~100 pointsPrediction of 28-day mortality

For the revised Baux score (Revised Baux Score = age + TBSA% + 17 × presence of inhalation burn), the reference point for a predicted 50% mortality (LD₅₀) is known to be about 130 points. When an inhalation burn is present, 17 points are added, making the predicted survival considerably less favorable.

Relationship between bronchoscopic classification (Mlcak Grade) and clinical outcome: Grade 0~I is mild, with conservative treatment; Grade II is moderate, with close monitoring; Grade III~IV is severe, with intubation and ICU treatment as the rule. However, bronchoscopic findings and the clinical course do not always agree, so active intervention is needed if the clinical condition worsens, even at Grade II.

S7. Oxygen therapy and hyperbaric oxygen therapy

In patients with inhalation burns, oxygen therapy is the most basic yet effective treatment. In CO toxicity, 100% oxygen shortens the half-life of COHb from about 4~5 hours when breathing room air to 60~90 minutes.

Hyperbaric oxygen therapy (HBO₂: Hyperbaric Oxygen Therapy): Breathing 100% oxygen at 2.4~3.0 atmospheres further shortens the COHb half-life to about 23 minutes. Dissolved oxygen (dissolved O₂) also increases, so adequate tissue oxygenation becomes possible with plasma alone. HBO₂ also helps resolve CO toxicity at the cellular level (cytochrome oxidase inhibition).

Indications for HBO₂ in CO poisoning (professional society recommendations):

In Korea, hyperbaric oxygen facilities are limited, and the risks of transporting burn patients must be considered. When inhalation burns and extensive skin burns coexist, the risks versus benefits of HBO₂ are carefully assessed. When there is heat-induced upper airway edema, airway management in a hyperbaric environment can be difficult, so it is safer to perform HBO₂ after intubation.

HBO₂ and neurological sequelae: In the randomized controlled trial by Weaver et al. (2002), HBO₂ significantly reduced cognitive sequelae after CO poisoning (25% vs 46%, p=0.007). However, HBO₂ is not applicable to all CO poisoning patients, and selection by indication is important.

S8. ICU transfer criteria and transfer to burn centers

Survival of burn patients with concomitant inhalation burns improves when they are treated in a specialized burn center or burn ICU. The ABA burn center referral criteria include inhalation burn alone as an indication for transfer.

Transfer criteria (based on ABA 2018 criteria):

Representative specialized burn institutions in Korea include Hallym University Hangang Sacred Heart Hospital, Bestian Hospital and the National Medical Center burn center, and when an inhalation burn is confirmed, the principle is transfer as early as possible. During transport, 100% oxygen is continued, airway status is reassessed repeatedly, and the need for prophylactic intubation before transport is determined. For long-distance transport, intubation before transport is safer if the risk of developing stridor is high.

S9. Combined carbon monoxide and hydrogen cyanide poisoning

CO and HCN are often present simultaneously in fire smoke. Combined poisoning with the two toxins shows much more severe toxicity than single exposure, with a mutually potentiating effect (synergism).

Mechanism of combined CO-HCN poisoning: CO binds hemoglobin and impairs oxygen transport in the blood (reduced oxygen supply), and HCN inhibits cytochrome oxidase (complex IV) in cellular mitochondria, preventing cells from using oxygen (reduced oxygen utilization). When the two mechanisms act simultaneously, tissue oxygen deficiency becomes extreme. Serum lactate >10 mmol/L is a strong indicator of HCN toxicity.

HCN antidotes:

In patients with combined poisoning, hydroxocobalamin is preferred because it can be used safely even when CO is present. After administration, neurological response (recovery of consciousness) and hemodynamic stabilization are assessed.

S10. Special features of pediatric inhalation burns

In children, the clinical features and treatment of inhalation burns differ because of anatomical and physiological characteristics that differ from adults. Children have small airway diameters (a 1 mm reduction in diameter increases airflow resistance 16-fold), so the risk of airway obstruction from mucosal edema is much higher than in adults.

Pediatric-specific considerations:

In pediatric inhalation burns, bronchoscopy is performed under general anesthesia, and the nebulized heparin/NAC protocol can be applied in the same way as in adults (Desai 1998). Selection of pediatric endotracheal tube size (internal diameter = age/4 + 4 mm for uncuffed; age/4 + 3.5 for cuffed) and adjustment of mechanical ventilation settings based on pediatric-specific predicted body weight are needed.

S11. Multidisciplinary approach and burn critical care management

Optimal management of patients with severe inhalation burns requires close collaboration of a multidisciplinary team. Burn surgery, critical care medicine, pulmonology, otolaryngology, clinical pharmacy, respiratory physiotherapy and clinical psychology are core team members.

Daily ICU management checklist:

When burn wound surgery is combined with critical care for inhalation burns, airway status is reassessed before induction of anesthesia, and mechanical ventilation settings are adjusted during surgery. When wound care under local anesthesia is possible, it is considered first to reduce the risks of general anesthesia.

S12. Prognosis and long-term follow-up management

The prognosis of inhalation burns (T27.3) varies greatly with the causative agent, extent of injury, concomitant skin burns, promptness of treatment and occurrence of complications. With inhalation burns, mortality is 2~4 times higher than for skin burns of the same TBSA.

Prognostic models: the Revised Baux Score, ABSI, FLAMES Score and others are used. In general, bronchoscopic Grade III or higher, PaO₂/FiO₂ <200 (severe ARDS), serum lactate >8 mmol/L (HCN toxicity) and COHb >25% are indicators of poor prognosis.

Long-term follow-up (6 months~5 years):

Delayed neurological sequelae (DNS) after CO poisoning are the new onset of parkinsonism, personality changes, cognitive impairment, urinary incontinence and the like 2~40 days after the initial CO poisoning symptoms have resolved, and particular attention is needed in patients with a history of initial loss of consciousness. There is evidence that early HBO₂ therapy helps prevent DNS.

If residual disability persists even after special copayment reduction V250 ends (1 year), patients are guided through industrial accident or disability assessment procedures and linked to ongoing pulmonary rehabilitation programs.

S13. References

  1. Walker PF, Buehner MF, Wood LA, et al. Diagnosis and management of inhalation injury: an updated review. Crit Care. 2015;19:351. doi:10.1186/s13054-015-1077-4. PMID: 26507130.
  2. Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med. 2002;347(14):1057-1067. doi:10.1056/NEJMoa013121. PMID: 12362006.
  3. Hampson NB, Piantadosi CA, Thom SR, Weaver LK. Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning. Am J Respir Crit Care Med. 2012;186(11):1095-1101. doi:10.1164/rccm.201207-1283CI. PMID: 23087028.
  4. Anseeuw K, Duerinckx N, Sabbe M, Peeters B. Evaluation and management of inhalation injury: a review. Acta Clin Belg. 2012;67(6):401-407. doi:10.2143/ACB.67.6.2062647. PMID: 23402059.
  5. Dries DJ, Endorf FW. Inhalation injury: epidemiology, pathology, treatment strategies. Scand J Trauma Resusc Emerg Med. 2013;21:31. doi:10.1186/1757-7241-21-31. PMID: 23597126.
  6. Sheridan RL. Fire-related inhalation injury. N Engl J Med. 2016;375(5):464-469. doi:10.1056/NEJMra1601128. PMID: 27518663.
  7. Mlcak RP, Suman OE, Herndon DN. Respiratory management of inhalation injury. Burns. 2007;33(1):2-13. doi:10.1016/j.burns.2006.09.014. PMID: 17141412.
  8. Forsberg S, Höjer J, Ludwigs U, Mårtenson L. Cyanide-induced hyperlactatemia: pathophysiology and clinical implications. Clin Toxicol (Phila). 2010;48(5):417-421. doi:10.3109/15563650.2010.481784. PMID: 20560817.
  9. Lung fireground exposure in Korean firefighters: Kim TH, Lee CH, Lee YH. Occupational inhalation exposure and respiratory health in Korean firefighters. Ann Occup Environ Med. 2017;29:26. doi:10.1186/s40557-017-0182-6. PMID: 28702215.
  10. American Burn Association. Advanced Burn Life Support Course: Provider Manual. 2018 Edition. Chicago: American Burn Association; 2018.